Ketogenic diet therapy addresses the energy requirements of glaucoma patients and inhibits the inflammatory response by activating the lactate-GPR81 signalling pathway and inhibiting AMPK/NF-κB signalling and NLRP3 inflammasome activation [98]. This evidence concerns the gene NLRP3 and glaucoma.